362 related articles for article (PubMed ID: 10642175)
21. Integrin alphaMbeta2 orchestrates and accelerates plasminogen activation and fibrinolysis by neutrophils.
Pluskota E; Soloviev DA; Bdeir K; Cines DB; Plow EF
J Biol Chem; 2004 Apr; 279(17):18063-72. PubMed ID: 14769799
[TBL] [Abstract][Full Text] [Related]
22. Effect of purified, soluble urokinase receptor on the plasminogen-prourokinase activation system.
Behrendt N; Danø K
FEBS Lett; 1996 Sep; 393(1):31-6. PubMed ID: 8804418
[TBL] [Abstract][Full Text] [Related]
23. The construction and expression of chimeric urokinase-type plasminogen activator genes containing kringle domains of human plasminogen.
Boutaud A; Castellino FJ
Arch Biochem Biophys; 1993 Jun; 303(2):222-30. PubMed ID: 8512311
[TBL] [Abstract][Full Text] [Related]
24. Activation of human pro-urokinase by unrelated proteases secreted by Pseudomonas aeruginosa.
Beaufort N; Seweryn P; de Bentzmann S; Tang A; Kellermann J; Grebenchtchikov N; Schmitt M; Sommerhoff CP; Pidard D; Magdolen V
Biochem J; 2010 May; 428(3):473-82. PubMed ID: 20337595
[TBL] [Abstract][Full Text] [Related]
25. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB
J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685
[TBL] [Abstract][Full Text] [Related]
26. Esterase A is a proteinase from rat urine that can activate plasminogen.
Ryan TJ; Keegan MC; McMartin DN; Dickerman HW
Biochim Biophys Acta; 1984 Jul; 800(1):87-95. PubMed ID: 6234943
[TBL] [Abstract][Full Text] [Related]
27. Activation of plasminogen by pro-urokinase. I. Mechanism.
Lijnen HR; Zamarron C; Blaber M; Winkler ME; Collen D
J Biol Chem; 1986 Jan; 261(3):1253-8. PubMed ID: 2935528
[TBL] [Abstract][Full Text] [Related]
28. Autoactivation of avian urokinase-type plasminogen activator (uPA). A novel mode of initiation of the uPA/plasmin cascade.
Alexander DS; Sipley JD; Quigley JP
J Biol Chem; 1998 Mar; 273(13):7457-61. PubMed ID: 9516444
[TBL] [Abstract][Full Text] [Related]
29. Regulated localization confers multiple functions on the protease urokinase plasminogen activator.
Wells JM; Strickland S
J Cell Physiol; 1997 May; 171(2):217-25. PubMed ID: 9130470
[TBL] [Abstract][Full Text] [Related]
30. Activation of pro-uPA is critical for initial escape from the primary tumor and hematogenous dissemination of human carcinoma cells.
Bekes EM; Deryugina EI; Kupriyanova TA; Zajac E; Botkjaer KA; Andreasen PA; Quigley JP
Neoplasia; 2011 Sep; 13(9):806-21. PubMed ID: 21969814
[TBL] [Abstract][Full Text] [Related]
31. Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo.
Suelves M; López-Alemany R; Lluís F; Aniorte G; Serrano E; Parra M; Carmeliet P; Muñoz-Cánoves P
Blood; 2002 Apr; 99(8):2835-44. PubMed ID: 11929773
[TBL] [Abstract][Full Text] [Related]
32. Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system.
Yin S; Lockett J; Meng Y; Biliran H; Blouse GE; Li X; Reddy N; Zhao Z; Lin X; Anagli J; Cher ML; Sheng S
Cancer Res; 2006 Apr; 66(8):4173-81. PubMed ID: 16618739
[TBL] [Abstract][Full Text] [Related]
33. Regulation of plasminogen activation by human U937 promonocytic cells.
Duval-Jobe C; Parmely MJ
J Biol Chem; 1994 Aug; 269(33):21353-7. PubMed ID: 8063761
[TBL] [Abstract][Full Text] [Related]
34. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
Kobayashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
[TBL] [Abstract][Full Text] [Related]
35. Plasminogen activation with single-chain urokinase-type plasminogen activator (scu-PA). Studies with active site mutagenized plasminogen (Ser740----Ala) and plasmin-resistant scu-PA (Lys158----Glu).
Lijnen HR; Van Hoef B; Nelles L; Collen D
J Biol Chem; 1990 Mar; 265(9):5232-6. PubMed ID: 1969415
[TBL] [Abstract][Full Text] [Related]
36. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes.
Lijnen HR; Van Hoef B; Lupu F; Moons L; Carmeliet P; Collen D
Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1035-45. PubMed ID: 9672063
[TBL] [Abstract][Full Text] [Related]
37. Antibody-mediated targeting of the urokinase-type plasminogen activator proteolytic function neutralizes fibrinolysis in vivo.
Lund IK; Jögi A; Rønø B; Rasch MG; Lund LR; Almholt K; Gårdsvoll H; Behrendt N; Rømer J; Høyer-Hansen G
J Biol Chem; 2008 Nov; 283(47):32506-15. PubMed ID: 18799467
[TBL] [Abstract][Full Text] [Related]
38. [The clinical prospects for the study of the plasminogen activation system in breast cancer].
Gershteĭn ES; Kushlinskiĭ NE
Vestn Ross Akad Med Nauk; 1999; (8):58-61. PubMed ID: 10487126
[TBL] [Abstract][Full Text] [Related]
39. A T-cell-related proteinase expressed by T-lymphoma cells activates their endogenous pro-urokinase.
Brunner G; Vettel U; Jobstmann S; Kramer MD; Schirrmacher V
Blood; 1992 Apr; 79(8):2099-106. PubMed ID: 1562736
[TBL] [Abstract][Full Text] [Related]
40. Potentiation of plasminogen activation by an anti-urokinase monoclonal antibody due to ternary complex formation. A mechanistic model for receptor-mediated plasminogen activation.
Ellis V; Danø K
J Biol Chem; 1993 Mar; 268(7):4806-13. PubMed ID: 8444857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
